MedPath

PMS-BEZAFIBRATE

PMS-BEZAFIBRATE

Dormant
DIN Number

02240331

Drug Class

Human

Market Date

Sep 1, 1999

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240331
AIG Number0122820002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AB02 BEZAFIBRATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

BEZAFIBRATEActive
Strength: 200 MG
Monograph: BEZAFIBRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.